Connection

P Rajagopalan to Antibodies, Monoclonal

This is a "connection" page, showing publications P Rajagopalan has written about Antibodies, Monoclonal.
Connection Strength

0.223
  1. OKT4 epitope correlates with renal allograft survival in African Americans. Cytometry. 1994 Jun 15; 18(2):93-4.
    View in: PubMed
    Score: 0.096
  2. A phase I/II randomized open-label multicenter trial of efalizumab, a humanized anti-CD11a, anti-LFA-1 in renal transplantation. Am J Transplant. 2007 Jul; 7(7):1770-7.
    View in: PubMed
    Score: 0.059
  3. Population pharmacokinetics and exposure-response relationships for basiliximab in kidney transplantation. The U.S. Simulect Renal Transplant Study Group. Transplantation. 1999 Nov 15; 68(9):1288-94.
    View in: PubMed
    Score: 0.035
  4. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group. Transplantation. 1999 Jan 27; 67(2):276-84.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.